http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103319470-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 |
filingDate | 2012-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103319470-B |
titleOfInvention | Compound based on the structures of Sant 75 |
abstract | The present invention relates to a kind of compound based on the structures of Sant 75, modified by the structure to Sant 75 there is provided at least one compound based on the structures of Sant 75 with more preferable biological activity, its structural formula can be: Wherein, R 1 For H, F or Cl;‑R 2 For H, F or OH;‑R 3 For H, F, Cl, OH, NO 2 、‑NH 2 、‑Me、‑SO 2 Me、‑CO 2 Me、‑CO 2 H, NHAc or NHSO 2 Me;‑R 4 For H, F, Cl or SO 2 Me;And R 1 、‑R 2 、‑R 3 And R 4 It is asynchronously H.The above-mentioned compound based on the structures of Sant 75, by carrying out the structural modification of system to Sant 75, relative to Sant 75, it is higher as the biological activity of seven membrane-spanning protein inhibitor. |
priorityDate | 2012-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.